Emergent Product Development Gaithersburg Inc.
Records under this name other than the patents Emergent Product Development Gaithersburg Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 10 patents it holds.
Back to Emergent Product Development Gaithersburg Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,883,172 | Chemically modified peptides with improved immunogenicity Formerly held In force · USPTO record | In force | USPTO record | |
| US 8,445,670 | Combinatorial Library Approach to Iminocyclitols with Biological Activity Formerly held Lapsed on the fee record Ended May 21, 2025 · Medium confidence | Lapsed on the fee record | Ended May 21, 2025 | Medium confidence |
| US 9,403,818 | Antimicrobial 4-oxoquinolizines Lapsed on the fee record Ended Aug 2, 2024 · USPTO record | Lapsed on the fee record | Ended Aug 2, 2024 | USPTO record |
| US 7,645,456 | Vaccinia Virus Strains Lapsed on the fee record Ended Jan 12, 2022 · Medium confidence | Lapsed on the fee record | Ended Jan 12, 2022 | Medium confidence |
| US 7,115,270 | Smallpox Vaccine Term ended Ended no later than Aug 26, 2021 · Medium confidence | Term ended | Ended no later than Aug 26, 2021 | Medium confidence |
| US 6,723,325 | Smallpox Vaccine Term ended Term ended May 7, 2021 · High confidence | Term ended | Term ended May 7, 2021 | High confidence |
| US 7,459,524 | Chlamydia protein, sequence and uses thereof Formerly held Lapsed on the fee record Ended Dec 2, 2016 · USPTO record | Lapsed on the fee record | Ended Dec 2, 2016 | USPTO record |
| US 7,442,373 | Antibodies against protective antigen and methods of use for passive immunization and treatment of anthrax Lapsed on the fee record Ended Oct 28, 2016 · USPTO record | Lapsed on the fee record | Ended Oct 28, 2016 | USPTO record |
| US 7,438,909 | Immunization and treatment methods for anthrax Lapsed on the fee record Ended Oct 21, 2016 · USPTO record | Lapsed on the fee record | Ended Oct 21, 2016 | USPTO record |
| US 7,419,807 | Chlamydia protein, gene sequence and uses thereof Lapsed on the fee record Ended Sep 2, 2016 · USPTO record | Lapsed on the fee record | Ended Sep 2, 2016 | USPTO record |